Michael Davidson
Impact in
-
- Menopause: Health Impacts and Treatments
- Diabetes Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Biological Psychiatry top 1%
Papers in
-
- Schizophrenia research and treatment 53
- Dementia and Cognitive Impairment Research 8
-
- Tryptophan and brain disorders 7
- Co-authors
- Perla WernerNanette K. WengerRoger S. BlumenthalDavid HerringtonAlan HerdL. Kristin NewbyDavid D. WatersVera Bittner
- Journals
- Schizophrenia Research (21 papers)Schizophrenia Bulletin (7 papers)American Journal of Psychiatry (7 papers)Biological Psychiatry (5 papers)European Neuropsychopharmacology (5 papers)
- Partner nations
- United StatesIsraelCyprus
In The Last Decade
Michael Davidson
111 papers receiving 6.7k citations
Hit Papers
Peers
Comparison fields: 5 of 152
- Endocrinology, Diabetes and Metabolism 2.4k
- Biological Psychiatry 355
- Psychiatry and Mental health 1.4k
- Pharmacology 1.0k
- Genetics 1.0k
Countries citing papers authored by Michael Davidson
This map shows the geographic impact of Michael Davidson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Davidson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Davidson more than expected).
Fields of papers citing papers by Michael Davidson
This network shows the impact of papers produced by Michael Davidson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Davidson. The network helps show where Michael Davidson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Davidson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 12 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 5 | |
| 6 | 2022 | 2 | |
| 7 | United States v. Friday and the Future of Native American Religious Challenges to the Bald and Golden Eagle Protection Act | 2020 | 0 |
| 8 | 2020 | 54 | |
| 9 | 2019 | 36 | |
| 10 | 2012 | 154 | |
| 11 | 2011 | 5 | |
| 12 | 2011 | 56 | |
| 13 | 2007 | 128 | |
| 14 | 2002 | 16 | |
| 15 | 2000 | 7 | |
| 16 | Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat Hit paper breakdown → | 1999 | 705 |
| 17 | 1997 | 146 | |
| 18 | 1994 | 47 | |
| 19 | 1993 | 9 | |
| 20 | 1992 | 92 |
About Michael Davidson
Michael Davidson is a scholar working on Psychiatry and Mental health, Biological Psychiatry, Philosophy, Neuropsychology and Physiological Psychology and Experimental and Cognitive Psychology, having authored 121 papers that have together received 7.0k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (53 papers), Mental Health and Psychiatry (14 papers), Lipoproteins and Cardiovascular Health (13 papers), Mental Health Research Topics (11 papers), Dementia and Cognitive Impairment Research (8 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers), Tryptophan and brain disorders (7 papers) and Functional Brain Connectivity Studies (7 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.4k citations), Biological Psychiatry (355 citations), Psychiatry and Mental health (1.4k citations), Pharmacology (1.0k citations) and Genetics (1.0k citations). Michael Davidson has collaborated with scholars based in United States, Israel and Cyprus. Frequent co-authors include Perla Werner, Nanette K. Wenger, Roger S. Blumenthal, David Herrington, Alan Herd, L. Kristin Newby, David D. Waters, Vera Bittner, Eric Vittinghoff and Deborah Grady. Their work appears in journals such as Schizophrenia Research, Schizophrenia Bulletin, American Journal of Psychiatry, Biological Psychiatry and European Neuropsychopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.